Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46.6M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
-934K
-
Total reported value, excl. options
-
$17M
-
Value change
-
-$3.22M
-
Number of buys
-
12
-
Number of sells
-
-28
-
Price
-
$1.45
Significant Holders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) as of Q2 2025
46 filings reported holding CAMP - Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share as of Q2 2025.
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 46.6M outstanding shares and own 25.19% of the company stock.
Largest 10 shareholders include ENAVATE SCIENCES GP, LLC (3.79M shares), 5AM Venture Management, LLC (2.93M shares), AH CAPITAL MANAGEMENT, L.L.C. (2.13M shares), HarbourVest Partners LLC (1.27M shares), FMR LLC (608K shares), VANGUARD GROUP INC (329K shares), Alyeska Investment Group, L.P. (200K shares), MILLENNIUM MANAGEMENT LLC (133K shares), BlackRock, Inc. (84.2K shares), and VICTORY CAPITAL MANAGEMENT INC (83.1K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.